RIVastigmine In Vascular cognitivE Impairment

Clinical trial NCT00669344 · COMPLETED

Trial details

NCT number: NCT00669344
Sponsor: Singapore General Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Cognitive Impairment

Start date: 2006-02-01
Primary completion: 2007-04-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.